Reaction

Renal Salt-Wasting Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 390 reports · 4 co-occurring drugs

As of the last recalculation, Renal Salt-Wasting Syndrome appears in 390 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is CISPLATIN (PRR 184.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Cisplatin160184.7185.0
Etoposide136151.0151.3
Carboplatin9250.350.3
Bleomycin Sulfate842.242.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.